东南国防医药
東南國防醫藥
동남국방의약
JOURNAL OF SOUTHEAST CHINA NATIONAL DEFENCE MEDICAL SCIENCE
2015年
1期
46-48
,共3页
王效雷%罗婕%丁兆霞%曹地芹%娄瑞
王效雷%囉婕%丁兆霞%曹地芹%婁瑞
왕효뢰%라첩%정조하%조지근%루서
导尿管相关性尿路感染%病原体%抗菌药物%细菌耐药率
導尿管相關性尿路感染%病原體%抗菌藥物%細菌耐藥率
도뇨관상관성뇨로감염%병원체%항균약물%세균내약솔
catheter associated urinary tract infection ( CAUTI)%pathogens%antimicrobial drug%bacterial resistance rate
目的:掌握导尿管相关性尿路感染( catheter associated urinary tract infection ,CAUTI)的病原体分布以及耐药性特征,为控制尿路感染提供依据。方法通过统计2012年1月-2014年6月解放军81医院119例CAUTI尿液微生物培养及药敏结果,分析CAUTI病原体分布及耐药性特征。结果119例CAUTI尿液标本中检出病原菌97株,前6位病原体依次为大肠埃希菌(26.80%)、粪肠球菌(15.46%)、白色念珠菌(11.34%)、屎肠球菌(10.31%)、铜绿假单胞菌(5.15%)和凝固酶阴性葡萄球菌(5.15%),并呈现出多耐药性,部分耐药率超过2013年Chinet的相关监测结果。结论应加强CAUTI病原体耐药性监测和临床合理用药监管,重视对多重耐药菌的隔离预防和对CAUTI的预防干预。
目的:掌握導尿管相關性尿路感染( catheter associated urinary tract infection ,CAUTI)的病原體分佈以及耐藥性特徵,為控製尿路感染提供依據。方法通過統計2012年1月-2014年6月解放軍81醫院119例CAUTI尿液微生物培養及藥敏結果,分析CAUTI病原體分佈及耐藥性特徵。結果119例CAUTI尿液標本中檢齣病原菌97株,前6位病原體依次為大腸埃希菌(26.80%)、糞腸毬菌(15.46%)、白色唸珠菌(11.34%)、屎腸毬菌(10.31%)、銅綠假單胞菌(5.15%)和凝固酶陰性葡萄毬菌(5.15%),併呈現齣多耐藥性,部分耐藥率超過2013年Chinet的相關鑑測結果。結論應加彊CAUTI病原體耐藥性鑑測和臨床閤理用藥鑑管,重視對多重耐藥菌的隔離預防和對CAUTI的預防榦預。
목적:장악도뇨관상관성뇨로감염( catheter associated urinary tract infection ,CAUTI)적병원체분포이급내약성특정,위공제뇨로감염제공의거。방법통과통계2012년1월-2014년6월해방군81의원119례CAUTI뇨액미생물배양급약민결과,분석CAUTI병원체분포급내약성특정。결과119례CAUTI뇨액표본중검출병원균97주,전6위병원체의차위대장애희균(26.80%)、분장구균(15.46%)、백색념주균(11.34%)、시장구균(10.31%)、동록가단포균(5.15%)화응고매음성포도구균(5.15%),병정현출다내약성,부분내약솔초과2013년Chinet적상관감측결과。결론응가강CAUTI병원체내약성감측화림상합리용약감관,중시대다중내약균적격리예방화대CAUTI적예방간예。
Objective To obtain the pathogens distribution and drug resistance characteristics of catheter associated urinary tract infection (CAUTI), so as to provide the evidence of controlling urinary tract infection .Methods 119 cases of CAUTI microbial culture and drug sensitive were collected and analyzed from January 2012 to June 2014.Results Isolated 97 pathogens from 119 urine specimens.Top 6 pathogens were:Escherichia coli (26.80%), Enterococcus faecalis (15.46%), Candida albicans (11.34%), Feces Enterococcus (10.31%), Pseudomonas aeruginosa (5.15%), Coagulase negative staphylococcus (5.15%), and the multi-drug-resistance was found.Some bacterial resistance rate was higher than the results of chinet 2013 surveillance.Conclusion The surveillance of bacterial resistance and the supervision of clinical rational drug use should be enhanced , and the further heavy interven-tions should be necessary to prevent the contact transmission of the multidrug -resistant organisms and CAUTI also .